Is a complete COCH research report available?

No complete published report is available for Envoy Medical, Inc. (COCH) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Envoy Medical, Inc. (COCH)

NASDAQ: COCH · USD

$0.67

+0.02 (+3.6%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first COCH analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	51.2M
Revenue (ttm)	234K
Net income (ttm)	-28.1M
EPS (ttm)	-$0.80
Shares out	76.9M
Volume	50,781
Beta	1.86
Price target	$2.25	+237.6%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 234K
Net income (ttm): -28.1M
EPS (ttm): -$0.80
Market cap: 51.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All COCH indicators

Market & fundamental data

Available fields

204

Groups with data

Currency

USD

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001840877
Company name	Envoy Medical, Inc.
Country	United States
Country code	US
Cusip	29415V109
Employees	47
Employees Change	5%
Employees Change Percent	11.9
Enterprise value	$26.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Industry PE	41
Industry PE Fwd	19.92
Isin	US29415V1098
Last refreshed	2026-07-31
Market cap	$51.2M
Market cap category	Micro-Cap
Price	$0.67
Price currency	USD
Rev Per Employee	4,978.72x
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	3842
Symbol	COCH
Website	https://www.envoymedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-55.11%
EV Sales Forward	78.45x
EV/Sales	113.98x
FCF yield	-40.58%
P/B ratio	4.69x
P/S ratio	218.09x
PS Forward	150.1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-9,881.2%
EBITDA Margin	-9,747.01%
Gross margin	-229.49%
Gross Profit	$-537,000
Net Income	$-28.1M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-9,875.64%
Profit Per Employee	$-598,447
ROA	-71.29
ROCE	-131.3
ROIC	-254.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-56.18%
Cagr3y	-59.86%
Cagr5y	-41.41%
EPS Growth Quarters	3
EPS Growth Years	2
Revenue Growth	10.38x
Revenue Growth Q	-15.22x
Revenue Growth Years	1x
Revenue Growth3 Y	3.02x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$29.8M
Cash	$25.3M
Current Assets	$27.7M
Current Liabilities	$12.2M
Debt	$889,000
Debt Equity	$0.08
Equity	$10.6M
Interest Coverage	-21.12
Liabilities	$19.3M
Long Term Assets	$2.1M
Long Term Liabilities	$7.1M
Net Cash	$24.4M
Net Cash By Market Cap	$47.74
Net Debt Equity	$-2.31
Tangible Book Value	$10.6M
Tangible Book Value Per Share	$0.14
WACC	15.91

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.27
Inventory Turnover	0.49
Net Working Capital	$-9.6M
Quick ratio	2.07
Working Capital	$15.5M
Working Capital Turnover	$0.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-80.58%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-56.15%
200-day SMA	0.71
3Y total return	-93.54%
50-day SMA	0.69
50-day SMA vs 200-day SMA	50under200
5Y total return	-93.09%
All Time High	11.72
All Time High Change	-94.31%
All Time High Date	2023-09-26
All Time Low	0.36
All Time Low Change	83.86%
All Time Low Date	2026-02-11
ATR	0.06
Beta	1.86
Beta1y	1.1
Beta2y	0.22
Ch YTD	0.82
High	0.67
High52	1.89
High52 Date	2025-10-07
High52ch	-64.74%
Low	0.65
Low52	0.36
Low52 Date	2026-02-11
Low52ch	83.86%
Ma50ch	-3.59%
Premarket Change Percent	0.26
Premarket Price	$0.65
Premarket Volume	331
Price vs 200-day SMA	-5.93%
RSI	46.54
RSI Monthly	31.9
RSI Weekly	45.48
Sharpe ratio	0.04x
Sortino ratio	0.13
Total Return	-80.58%
Tr YTD	0.82
Tr1m	-2.42%
Tr1w	0.83%
Tr3m	-1.52%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Count Top	0
Analyst Ratings	Buy
Earnings EPS Estimate	$-0.08
Earnings Revenue Estimate	60,000x
Earnings Revenue Estimate Growth	-23.08x
Operating Income	$-22.9M
Operating margin	-9,800
Price target	$2.25
Price Target Change	$238

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	38,092,078%
Float Percent	49.55%
Net Borrowing	4,098,000
Shares Insiders	37.22%
Shares Institutions	13.37%
Shares Out	76,881,110
Shares Qo Q	142.13%
Shares Yo Y	80.58%
Short Float	2.31%
Short Ratio	1.08
Short Shares	1.14

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-21.6M
Adjusted OCF	-21,405,000
Average Volume	354,363.45x
Bv Per Share	0.14
CAPEX	$-173,000
Ch1m	-2.42
Ch1w	0.83
Ch1y	-56.15
Ch3m	-1.52
Ch3y	-93.54
Ch5y	-93.09
Ch6m	0.11
Change	3.61%
Change From Open	2.21
Close	0.64
Days Gap	1.37
Depreciation Amortization	314,000
Dollar Volume	33,845.5
Earnings Date	2026-08-11
Earnings Time	bmo
EBIT	$-23.1M
EBITDA	$-22.8M
EPS	$-0.8
F Score	3
FCF	$-20.7M
FCF EV Yield	-77.65x
FCF Per Share	$-0.27
Financing CF	40,653,000
Fiscal Year End	December
Founded	1,995
Investing CF	-173,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-11
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-23
Ma150	0.68
Ma150ch	-2.67%
Ma20	0.7
Ma20ch	-5.12%
Net CF	19,939,000
Next Earnings Date	2026-08-11
Open	0.65
Optionable	No
Position In Range	73.47
Post Close	0.67
Postmarket Change Percent	-0.62
Postmarket Price	$0.66
Ppne	1,815,000
Pre Close	0.64
Price Date	2026-07-30
Ptbv Ratio	4.84
Relative Volume	0.14x
Revenue	234,000x
SBC By Revenue	370.94x
Share Based Comp	868,000
Tr6m	0.11%
Us State	Minnesota
Volume	50,781
Z Score	-15.95

Envoy Medical, Inc. (COCH)

Coverage state: Market snapshot only — no published research

Generate the first COCH analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · COCH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All COCH indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on COCH

Frequently asked questions